Smoking cessation with smokeless tobacco andgroup therapy: An open, randomized, controlled trial

Nicotine and Tobacco Research

Volumn 10, Issue 8, 2008, Pages 1365-1372

  Tønnesen, Philip ^a   Mikkelsen, Kim ^a   Bremann, Linda ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CLINICAL PROTOCOL; CLINICAL TRIAL; COLIC; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DRY THROAT; FATIGUE; FEMALE; FLUSHING; GROUP THERAPY; HEARTBURN; HICCUP; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH DISEASE; NURSE; OPEN STUDY; PATIENT COUNSELING; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKELESS TOBACCO; SMOKING CESSATION; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME; XEROSTOMIA;

ADULT; CHEWING GUM; DENMARK; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NICOTINE; PATIENT SATISFACTION; TIME FACTORS; TOBACCO USE CESSATION; TOBACCO USE DISORDER; TOBACCO, SMOKELESS; TREATMENT OUTCOME;

EID: 49049111839     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1080/14622200802238969     Document Type: Article

References (36)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, Author, Washington, DC
2. Bask, M. and Melkersson, M. (2003) Should one use smokeless tobacco in smoking cessation programs? A rational addiction approach. European Journal of Health Economics, 4, pp. 263-270.
3. Benowitz, N. L., Porchet, H., Sheiner, L. and Jacob, P. (1988) Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum. Clinical Pharmacology and Therapeutics, 44, pp. 23-28.
4. Bohadana, A., Nilsson, F., Rasmussen, T. and Martinet, Y. (2000) Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation. Archives of Internal Medicine, 2160, pp. 3128-3134.
5. Fagerstrom, K. O., Heatherton, T. F. and Kozlowski, L. T. (1991) Nicotine addiction and its assessment. Ear Nose and Throat Journal, 69, pp. 763-768.
6. Feyerabend, C. and Russell, M. A. H. (1990) Rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids. Journal of Pharmaceutical Pharmacology, 42, pp. 450-452.
7. Fiore, M. C., Bailey, W. C., Cohen, S. J., Dorfman, S. F., Goldstein, M. G. Gritz, E. R. et al. (2000) Treating tobacco use and dependence. Clinical practice guideline, U.S. Department of Health and Human Services. Public Health Service, Rockville, MD
8. Fowler, J. S., Logan, J., Wang, G. J. and Volkow, N. D. (2003) Monoamine oxidase and cigarette smoking. Neurotoxicology, 24, pp. 75-82.
9. Gonzales, D., Rennard, S. I., Nides, M., Oncken, C., Azoulog, S. Billing, C. B. et al. (2006) Varenicline, an alpha4beta2 receptor partial agonist vs sustained-release bupropion and placebo for smoking cessation. The Journal of the American Medical Association, 296, pp. 47-55.
10. Gritz, E. R., Baer-Weiss, V., Benowitz, N. L., Van Vunakis, H. and Jarvik, M. E. (1981) Plasma nicotine and cotinine concentrations in habitual smokeless tobacco users. Clinical Pharmacology and Therapeutics, 30, pp. 201-209.
11. Hatsukami, D. K., Lemmonds, C. and Tomar, S. L. (2004) Smokeless tobacco use: Harm reduction or induction approach?. Preventive Medicine, 38, pp. 309-317.
12. Hatsukami, D. K., Lemmonds, C., Zhang, Y., Murphy, S. E., Le, C. Camella, S. G. et al. (2004) Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products. Journal of the National Cancer Institute, 296, pp. 844-852.
13. Hays, J. T., Hurt, R. D., Rigotti, N. A., Azoulay, S., Watsky, E. J. Williams, K. E. et al. (2001) Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation: A randomised, controlled trial. Annals of Internal Medicine, 135, pp. 423-433.
14. Hjalmarson, A., Franzon, M., Westin, A. and Wiklund, O. (1994) Effect of nicotine nasal spray on smoking cessation. Archives of Internal Medicine, 154, pp. 2567-2572.
15. Hjalmarson, A., Nilsson, F., Sjostrom, L. and Wiklund, O. (1997) The nicotine inhaler in smoking cessation: A double-blind randomised clinical evaluation. Archives of Internal Medicine, 157, pp. 1721-1728.
16. Hurt, R. D., Sachs, D. P. L., Glover, E. D., Offord, K. P., Johnston, J. A. Dale, L. C. et al. (1997) A comparison of sustained release bupropion and placebo for smoking cessation. The New England Journal of Medicine, 337, pp. 1195-1220.
17. Jarvis, M. J., Primatesta, P., Erens, B., Feyerabend, C. and Bryant, A. (2003) Measuring nicotine intake in population surveys: Comparability of saliva cotinine and plasma cotinine estimates. Nicotine & Tobacco Research, 5, pp. 349-355.
18. Jarvis, M. J., Russell, M. A. and Saloojee, Y. (1980) Expired air carbon monoxide: A simple breath test of tobacco smoke intake. British Medical Journal, 281, pp. 484-485.
19. Jorenby, D. E., Hays, J. T., Rigotti, N. A., Azoulay, S., Watsky, E. J. Williams, K. E. et al. (2006) Efficacy of varenicline, an alpha4,beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation. The Journal of the American Medical Association, 296, pp. 56-63.
20. McNabb, M. E. (1984) Chewing nicotine gum for 3 months: What happens to plasma nicotine levels?. Canadian Medical Association Journal, 131, pp. 589-592.
21. McNabb, M. E., Ebert, R. V. and McCusker, K. (1982) Plasma nicotine levels produced by chewing nicotine gum. The Journal of the American Medical Association, 248, pp. 865-868.
22. McNeil, A., Bedi, R., Islam, S., Alkhatib, M. N. and West, R. (2006) Levels of toxins in oral tobacco products in the UK. Tobacco Control, 15, pp. 64-67.
23. National Institutes of Health (2006) NIH State-of-the-Science Panel National Institutes of Health State-of-the-Science conference statement. Tobacco use: Prevention, cessation, and control. Annals of Internal Medicine, 145:11, pp. 839-844.
24. Nørregaard, J., Tønnesen, P., Simonsen, K. and Sæwe, U. (1992) Long-term nicotine substitution after application of a 16-hour nicotine patch in smoking cessation. European Journal of Clinical Pharmacology, 43, pp. 57-60.
25. Rice, V. H. and Stead, L. F. (2004) Nursing interventions for smoking cessation. Nursing interventions for smoking cessation.
26. Rodu, B. and Jansson, C. (2004) Smokeless tobacco and oral cancer: A review of the risks and determinants. Critical Reviews in Oral Biology and Medicine, 15, pp. 252-263.
27. Siegel, D., Benowitz, N. L., Ernster, V. L., Grady, D. G. and Hauck, W. W. (1992) Smokeless tobacco, cardiovascular risk factors, and nicotine and cotinine levels in professional baseball players. American Journal of Public Health, 82, pp. 417-421.
28. Silagy, C., Lancaster, T., Stead, L., Mant, D. and Fowler, G. (2006) Nicotine replacement therapy for smoking cessation.
29. Stepanov, J., Jensen, J., Hatsukami, D. K. and Hecht, S. S. (2006) Tobacco specific nitrosamines in new tobacco products. Nicotine & Tobacco Research, 8, pp. 309-313.
30. Sutherland, G., Stapleton, J. A., Russell, M. A. H., Jarvis, M. J., Hajek, P. Belcher, M. et al. (1992) Randomised controlled trial of nasal nicotine spray in smoking cessation. The Lancet, 340, pp. 324-329.
31. Sutton, S. R., Russell, M. A. H., Iyer, I., Feyerabend, C. and Saloojee, Y. (1982) Relationship between cigarette yields, puffing patterns and smoke intake: Evidence for tar compensation?. British Medical Journal, 285, pp. 600-603.
32. Tønnesen, P., Nørregaard, J., Mikkelsen, K., Jørgensen, S. and Nilsson, F. (1993) A double-blind trial of a nicotine inhaler for smoking cessation. The Journal of the American Medical Association, 269, pp. 1268-1271.
33. Tønnesen, P., Nørregaard, J., Simonsen, K. and Sæwe, U. (1991) A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. The New England Journal of Medicine, 325, pp. 311-315.
34. Tønnesen, P., Paoletti, P., Gustavsson, G., Russell, M. A., Saracci, R. Gulsvik, A. et al. (1999) Higher dosage nicotine patches increase one-year smoking cessation rates: Results from the European CEASE trial. European Respiratory Journal, 13, pp. 238-246.
35. Tønnesen, P., Tonstad, S., Hjalmarson, A., Lebargy, F., van Spiegel, P. I. Hider, A. et al. (2003) A multicentre, randomised, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation. Journal of Internal Medicine, 254, pp. 184-192.
36. U.S. Department of Health and Human Services (1998) Nicotine addiction. A report of the surgeon general, Author, Rockville, MD